In vivo evaluation of a regenerative approach to nasal dorsum augmentation with a polycaprolactone-based implant
ConclusionOur results indicated that the investigated polycaprolactone-based implants have shown a regenerative and stable nasal dorsum augmentation after 6 months in vivo. Thus, we believe that customized polycaprolactone-based implants could become an alternative technique for nasal dorsum augmentation without the need for autologous cartilage grafts.
Source: European Journal of Medical Research - Category: Research Source Type: research